ABHD16A deficiency causes a complicated form of hereditary spastic paraplegia associated with intellectual disability and cerebral anomalies.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
07 10 2021
Historique:
received: 22 07 2021
accepted: 08 09 2021
pubmed: 30 9 2021
medline: 16 11 2021
entrez: 29 9 2021
Statut: ppublish

Résumé

ABHD16A (abhydrolase domain-containing protein 16A, phospholipase) encodes the major phosphatidylserine (PS) lipase in the brain. PS lipase synthesizes lysophosphatidylserine, an important signaling lipid that functions in the mammalian central nervous system. ABHD16A has not yet been associated with a human disease. In this report, we present a cohort of 11 affected individuals from six unrelated families with a complicated form of hereditary spastic paraplegia (HSP) who carry bi-allelic deleterious variants in ABHD16A. Affected individuals present with a similar phenotype consisting of global developmental delay/intellectual disability, progressive spasticity affecting the upper and lower limbs, and corpus callosum and white matter anomalies. Immunoblot analysis on extracts from fibroblasts from four affected individuals demonstrated little to no ABHD16A protein levels compared to controls. Our findings add ABHD16A to the growing list of lipid genes in which dysregulation can cause complicated forms of HSP and begin to describe the molecular etiology of this condition.

Identifiants

pubmed: 34587489
pii: S0002-9297(21)00341-4
doi: 10.1016/j.ajhg.2021.09.005
pmc: PMC8546048
pii:
doi:

Substances chimiques

ABHD16A protein, human EC 3.1.1.23
Monoacylglycerol Lipases EC 3.1.1.23

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2017-2023

Subventions

Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : CIHR
ID : MFE-176616
Pays : Canada
Organisme : CIHR
ID : FDN-154279
Pays : Canada

Informations de copyright

Copyright © 2021 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Nat Chem Biol. 2015 Feb;11(2):164-71
pubmed: 25580854
Biochim Biophys Acta. 2013 Apr;1831(4):792-802
pubmed: 23328280
J Inherit Metab Dis. 2020 Nov;43(6):1265-1278
pubmed: 32557630
Biochem Biophys Res Commun. 2008 Sep 12;374(1):147-51
pubmed: 18616930
Brain. 2014 Jul;137(Pt 7):1907-20
pubmed: 24833714
Hum Mutat. 2015 Oct;36(10):915-21
pubmed: 26295439
Lancet. 1983 May 21;1(8334):1151-5
pubmed: 6133167
Biochem Biophys Res Commun. 2009 Jan 23;378(4):783-8
pubmed: 19063864
Anticancer Res. 2014 Oct;34(10):5465-72
pubmed: 25275042
J Biol Chem. 2013 Feb 15;288(7):4583-93
pubmed: 23293064
Prog Lipid Res. 2012 Jul;51(3):199-207
pubmed: 22465125
Am J Hum Genet. 2010 Sep 10;87(3):410-7
pubmed: 20797687
Exp Neurol. 2013 Aug;246:14-25
pubmed: 22285450
Hum Genet. 2015 Jun;134(6):511-38
pubmed: 25758904
Biochemistry. 2020 Jun 23;59(24):2299-2311
pubmed: 32462874
Protein Eng. 1992 Apr;5(3):197-211
pubmed: 1409539
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Front Neurosci. 2020 Feb 28;14:74
pubmed: 32180696
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1500-5
pubmed: 23297193
Rev Neurol (Paris). 2015 Jun-Jul;171(6-7):505-30
pubmed: 26008818
Open Biol. 2018 May;8(5):
pubmed: 29794032
Am J Hum Genet. 2014 Jun 5;94(6):809-17
pubmed: 24906018

Auteurs

Gabrielle Lemire (G)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada; Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: glemire@cheo.on.ca.

Yoko A Ito (YA)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

Aren E Marshall (AE)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

Nicolas Chrestian (N)

Department of Paediatric Neurology, Paediatric Neuromuscular Disorder, Centre Mère Enfant Soleil, Laval University, Quebec City, QC G1V 4G2, Canada; Department of Molecular Medicine, Faculty of Medicine, Neuroscience Laboratory, CHU de Québec Research Center, Laval University, Quebec City, QC G1V 4G2, Canada.

Valentina Stanley (V)

Laboratory for Pediatric Brain Disease, Rady Children's Institute for Genomic Medicine, University of California, San Diego, San Diego, CA 92093, USA.

Lauren Brady (L)

Neuromuscular and Neurometabolics Division, Department of Pediatrics, McMaster University, Hamilton, ON L8N 3Z5, Canada.

Mark Tarnopolsky (M)

Neuromuscular and Neurometabolics Division, Department of Pediatrics, McMaster University, Hamilton, ON L8N 3Z5, Canada.

Cynthia J Curry (CJ)

Genetic Medicine Division, Department of Pediatrics, University of California, San Francisco, Fresno, CA 93701, USA.

Taila Hartley (T)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

Wendy Mears (W)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada.

Alexa Derksen (A)

Child Health and Human Development Program, McGill University Health Centre Research Institute, Montréal, QC H4A 3J1, Canada; Departments of Neurology and Neurosurgery, Pediatrics and Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada.

Nadie Rioux (N)

Department of Molecular Medicine, Faculty of Medicine, Neuroscience Laboratory, CHU de Québec Research Center, Laval University, Quebec City, QC G1V 4G2, Canada.

Nataly Laflamme (N)

Department of Molecular Medicine, Faculty of Medicine, Neuroscience Laboratory, CHU de Québec Research Center, Laval University, Quebec City, QC G1V 4G2, Canada.

Harrol T Hutchison (HT)

Neurology Division, Department of Pediatrics, University of California, San Francisco, Fresno, CA 93701, USA.

Lynn S Pais (LS)

Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Maha S Zaki (MS)

Clinical Genetics Department, Human Genetics and Genome Research Division, National Research Centre, 12311 Cairo, Egypt.

Tipu Sultan (T)

Department of Pediatric Neurology, Institute of Child Health, Children Hospital Lahore, 54000 Lahore, Pakistan.

Adrie D Dane (AD)

Bioinformatics Laboratory, Department of Epidemiology and Data Science, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam 1105, the Netherlands.

Joseph G Gleeson (JG)

Laboratory for Pediatric Brain Disease, Rady Children's Institute for Genomic Medicine, University of California, San Diego, San Diego, CA 92093, USA.

Frédéric M Vaz (FM)

Laboratory Genetic Metabolic Diseases, Amsterdam UMC, University of Amsterdam, Departments of Clinical Chemistry and Pediatrics, Amsterdam Gastroenterology and Endocrinology Metabolism, Amsterdam 1105, the Netherlands; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam 1105, the Netherlands; Core Facility Metabolomics, Amsterdam UMC, Amsterdam 1105, the Netherlands.

Kristin D Kernohan (KD)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada; Newborn Screening Ontario, Children's Hospital of Eastern Ontario, Ottawa, ON K1H 8L1, Canada.

Geneviève Bernard (G)

Genetic Medicine Division, Department of Pediatrics, University of California, San Francisco, Fresno, CA 93701, USA; Child Health and Human Development Program, McGill University Health Centre Research Institute, Montréal, QC H4A 3J1, Canada; Department of Specialized Medicine, Division of Medical Genetics, McGill University Health Center, Montreal, QC H4A 3J1, Canada.

Kym M Boycott (KM)

Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON K1H 8L1, Canada. Electronic address: kboycott@cheo.on.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH